BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer

San Rafael, (STL.News) – BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced the promotion of Lon Cardon, Ph.D. to Chief Scientific Strategy Officer, a newly created role to enrich BioMarin’s pipeline, which…

The post BioMarin Promotes Lon Cardon, Ph.D. to Chief Scientific Strategy Officer appeared first on STL.News.